elf Beauty Inc header image

elf Beauty Inc

ELF

Equity

ISIN US26856L1035 / Valor 33775016

New York Stock Exchange, Inc (2024-09-18)
USD 114.65+1.97%

elf Beauty Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Elf Beauty Inc is a cosmetics company that offers affordable and high-quality beauty products.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (14.08.2024):

Net Sales Growth

e.l.f. Beauty Inc. reported a significant 50% increase in net sales for the first quarter of fiscal 2025, reaching $324.5 million. This growth was primarily driven by strong performance in both retailer and e-commerce channels.

Gross Margin Improvement

For the first quarter of fiscal 2025, e.l.f. Beauty Inc. achieved a gross margin of 71%, an increase of approximately 80 basis points. This improvement was attributed to favorable foreign exchange impacts, lower transportation costs, price increases in international markets, cost savings, and product mix adjustments.

Net Income and Earnings Per Share

e.l.f. Beauty Inc. reported a net income of $47.6 million on a GAAP basis for the first quarter of fiscal 2025. Adjusted net income was $64.3 million, with diluted earnings per share at $0.81 on a GAAP basis and $1.10 on an adjusted basis.

Liquidity Position

As of June 30, 2024, e.l.f. Beauty Inc. had $109.0 million in cash and cash equivalents, with long-term debt and finance lease obligations totaling $159.2 million. This compares to $142.5 million in cash and cash equivalents and $59.6 million in long-term debt and finance lease obligations as of June 30, 2023.

Updated Fiscal 2025 Outlook

e.l.f. Beauty Inc. has raised its fiscal 2025 outlook, now expecting a 25-27% year-over-year increase in net sales, compared to the previously expected 20-22% increase. The updated net sales forecast is between $1,280 million and $1,300 million, with adjusted EBITDA projected to be between $297 million and $301 million.

Summarized from source with an LLMView Source

Key figures

-6.79%1Y
282%3Y
596%5Y

Performance

62.2%1Y
51.1%3Y
51.7%5Y

Volatility

Market cap

6465 M

Market cap (USD)

Daily traded volume (Shares)

431,763

Daily traded volume (Shares)

1 day high/low

118.47 / 112.43

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Align Technology Inc
Align Technology Inc Align Technology Inc Valor: 1159441
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.06%USD 253.01
Hologic Inc
Hologic Inc Hologic Inc Valor: 939263
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.34%USD 81.72
Bruker Corp
Bruker Corp Bruker Corp Valor: 1635622
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.72%USD 66.80
Masimo Corp
Masimo Corp Masimo Corp Valor: 493578
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.61%USD 114.31
Legend Biotech Corporation
Legend Biotech Corporation Legend Biotech Corporation Valor: 54834759
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.46%USD 49.91
DENTSPLY SIRONA Inc
DENTSPLY SIRONA Inc DENTSPLY SIRONA Inc Valor: 31773200
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.07%USD 26.71
Acadia Healthcare Co Inc
Acadia Healthcare Co Inc Acadia Healthcare Co Inc Valor: 14151414
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.22%USD 77.94
Roivant Sciences Limited
Roivant Sciences Limited Roivant Sciences Limited Valor: 113331044
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.41%USD 12.00
Apellis Pharmaceuticals Inc
Apellis Pharmaceuticals Inc Apellis Pharmaceuticals Inc Valor: 30132056
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.28%USD 35.63
QuidelOrtho Corporation
QuidelOrtho Corporation QuidelOrtho Corporation Valor: 119356965
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.26%USD 46.23